Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
In a filing, Plus Therapeutics Inc revealed its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
Plus Therapeutics Inc’s filing revealed that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22
Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug
Plus Therapeutics, Inc. (PTSV) stock prices were up an impressive 16.5% as of market close on April 21st, 2021, bringing
Stocks opened the week with a strong performance yesterday. All three major U.S. indices posted 1.0%+ gains. The tech-heavy Nasdaq